$337M | ||
$259M | ||
$79M | ||
$75M | ||
$60M | ||
$56M |
Buys | $1,018,826 | 6 | 100 |
Sells | $0 | 0 | 0 |
Opaleye Management Inc. | 10 percent owner | 6 | $1.02M | 0 | $0 | $1.02M |
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; and Rezipres, a ready-to-use formulation of a molecule that is indicated for the treatment of clinically …
Over the last 12 months, insiders at Eton Pharmaceuticals, Inc. have bought $1.02M and sold $0 worth of Eton Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Eton Pharmaceuticals, Inc. have bought $983,754 and sold $20.77M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Opaleye Management Inc. (10 percent owner) — $1.02M.
The last purchase of 10,000 shares for transaction amount of $79,814 was made by Opaleye Management Inc. (10 percent owner) on 2024‑10‑23.
2024-10-23 | Opaleye Management Inc. | 10 percent owner | 10,000 0.0782% | $7.98 | $79,814 | +64.21% | ||
2024-10-08 | Opaleye Management Inc. | 10 percent owner | 33,970 0.2339% | $7.03 | $238,782 | +75.68% | ||
2024-10-07 | Opaleye Management Inc. | 10 percent owner | 11,248 0.0796% | $7.22 | $81,250 | +77.53% | ||
2024-10-04 | Opaleye Management Inc. | 10 percent owner | 16,852 0.1118% | $6.77 | $114,105 | +84.57% | ||
2024-09-11 | Opaleye Management Inc. | 10 percent owner | 50,000 0.2326% | $4.75 | $237,500 | +160.54% | ||
2024-09-10 | Opaleye Management Inc. | 10 percent owner | 57,500 0.2619% | $4.65 | $267,375 | +160.67% | ||
2022-09-22 | BRYNJELSEN SEAN | Chief Executive Officer | 10,000 0.0382% | $2.10 | $21,042 | +61.06% | ||
2021-11-17 | Sale | Opaleye Management Inc. | 10 percent owner | 25,000 0.1% | $4.67 | $116,713 | -31.32% | |
2021-11-16 | Sale | Opaleye Management Inc. | 10 percent owner | 12,438 0.0495% | $4.86 | $60,472 | -34.12% | |
2021-11-15 | Sale | Opaleye Management Inc. | 10 percent owner | 3,000 0.0112% | $4.80 | $14,405 | -37.28% | |
2021-11-08 | Sale | Opaleye Management Inc. | 10 percent owner | 52,661 0.2268% | $6.10 | $321,285 | -41.81% | |
2021-11-05 | Sale | Opaleye Management Inc. | 10 percent owner | 167,701 0.6665% | $6.30 | $1.06M | -46.74% | |
2021-11-04 | Sale | Opaleye Management Inc. | 10 percent owner | 85,700 0.3409% | $6.44 | $551,651 | -47.20% | |
2021-11-03 | Sale | Opaleye Management Inc. | 10 percent owner | 116,500 0.4622% | $6.53 | $760,850 | -47.32% | |
2021-10-12 | Sale | Opaleye Management Inc. | 10 percent owner | 87,307 0.3414% | $5.06 | $441,485 | -28.85% | |
2021-10-11 | Sale | Opaleye Management Inc. | 10 percent owner | 34,101 0.136% | $5.01 | $170,716 | -26.61% | |
2021-10-08 | Sale | Opaleye Management Inc. | 10 percent owner | 43,692 0.1737% | $5.00 | $218,469 | -26.45% | |
2021-08-20 | BRYNJELSEN SEAN | President & CEO | 10,000 0.0388% | $4.32 | $43,200 | -12.02% | ||
2021-08-20 | Troutman William Wilson | CFO, Treasurer & Secretary | 5,000 0.0199% | $4.43 | $22,150 | -12.02% | ||
2021-08-06 | Sale | Opaleye Management Inc. | 10 percent owner | 345,000 1.358% | $5.84 | $2.01M | -32.88% |
Opaleye Management Inc. | 10 percent owner | 2770000 10.3291% | $32.82M | 7 | 17 | <0.0001% |
BRYNJELSEN SEAN | Chief Executive Officer | 1040000 3.8781% | $12.32M | 7 | 0 | <0.0001% |
CASAMENTO CHARLES J | director | 71920 0.2682% | $852,252.00 | 2 | 0 | +1.97% |
RIEDEL NORBERT G | director | 59745 0.2228% | $707,978.25 | 1 | 0 | +7.11% |
MAIER PAUL V | director | 59745 0.2228% | $707,978.25 | 1 | 0 | +7.11% |
Troutman William Wilson | CFO, Treasurer & Secretary | 23027 0.0859% | $272,869.95 | 2 | 0 | <0.0001% |
BAUM MARK L | director | 10000 0.0373% | $118,500.00 | 1 | 0 | +7.11% |
$24,384,691 | 42 | -30.27% | $306.51M | |
$109,415,500 | 33 | 18.13% | $298.57M | |
$73,401,597 | 25 | 46.98% | $307.9M | |
$26,923,982 | 20 | -17.22% | $347M | |
$100,566,697 | 18 | -5.10% | $317.53M |
Increased Positions | 54 | +150% | 4M | +44.71% |
Decreased Positions | 15 | -41.67% | 628,671 | -6.6% |
New Positions | 27 | New | 2M | New |
Sold Out Positions | 4 | Sold Out | 24,525 | Sold Out |
Total Postitions | 75 | +108.33% | 13M | +38.11% |
Opaleye Management Inc. | $33,740.00 | 10.56% | 2.85M | +72,070 | +2.59% | 2024-12-31 |
Ecor1 Capital, Llc | $21,644.00 | 6.78% | 1.83M | +1M | +223.21% | 2024-12-31 |
Nantahala Capital Management, Llc | $13,232.00 | 4.14% | 1.12M | +119,750 | +11.99% | 2024-12-31 |
Vanguard Group Inc | $12,584.00 | 3.94% | 1.06M | +36,019 | +3.5% | 2024-12-31 |
Westside Investment Management, Inc. | $6,805.00 | 2.13% | 575,222 | -43,453 | -7.02% | 2024-12-31 |
Mink Brook Asset Management Llc | $5,392.00 | 1.69% | 455,805 | +455,805 | New | 2024-12-31 |
Cannell Capital Llc | $4,511.00 | 1.41% | 381,323 | +381,323 | New | 2024-12-31 |
Blackrock, Inc. | $3,758.00 | 1.18% | 317,625 | +32,770 | +11.5% | 2024-12-31 |
Parkman Healthcare Partners Llc | $3,276.00 | 1.03% | 276,890 | +16,664 | +6.4% | 2024-12-31 |
Geode Capital Management, Llc | $3,178.00 | 1% | 268,646 | -4,050 | -1.49% | 2024-12-31 |